Related references
Note: Only part of the references are listed.Breast Cancer Susceptibility Variants and Mammographic Density Phenotypes in Norwegian Postmenopausal Women
Merete Ellingjord-Dale et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene-Environment Interactions
Anja Schoeps et al.
GENETIC EPIDEMIOLOGY (2014)
Volumetric Mammographic Density: Heritability and Association With Breast Cancer Susceptibility Loci
Judith S. Brand et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk
Sara Lindstroem et al.
NATURE COMMUNICATIONS (2014)
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
Rebecca Hein et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study
Anja Rudolph et al.
ENDOCRINE-RELATED CANCER (2013)
Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials
JoAnn E. Manson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Evidence of Gene-Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors
Stefan Nickels et al.
PLOS GENETICS (2013)
9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Helen Warren et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Changing Concepts: Menopausal Hormone Therapy and Breast Cancer
Rowan T. Chlebowski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
A Sustained Decline in Postmenopausal Hormone Use Results From the National Health and Nutrition Examination Survey, 1999-2010
Brian L. Sprague et al.
OBSTETRICS AND GYNECOLOGY (2012)
Novel Breast Cancer Susceptibility Locus at 9q31.2: Results of a Genome-Wide Association Study
Olivia Fletcher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Interactions Between Genetic Variants and Breast Cancer Risk Factors in the Breast and Prostate Cancer Cohort Consortium
Daniele Campa et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
Rowan T. Chlebowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study
Ruth C. Travis et al.
LANCET (2010)
Genome-wide association study identifies five new breast cancer susceptibility loci
Clare Turnbull et al.
NATURE GENETICS (2010)
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Roger L. Milne et al.
BREAST CANCER RESEARCH (2010)
Postmenopausal Hormone Use and Breast Cancer Associations Differ by Hormone Regimen and Histologic Subtype
Eugenia E. Calle et al.
CANCER (2009)
Variation in the FGFR2 Gene and the Effects of Postmenopausal Hormone Therapy on Invasive Breast Cancer
Ross L. Prentice et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women
Timothy R. Rebbeck et al.
CARCINOGENESIS (2009)
FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: Results of a case control study in Japan
Takakazu Kawase et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)
Gilles Thomas et al.
NATURE GENETICS (2009)
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1
Wei Zheng et al.
NATURE GENETICS (2009)
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
Shahana Ahmed et al.
NATURE GENETICS (2009)
Conjugated equine estrogens and breast cancer risk in the women's health initiative clinical trial and observational study
Ross L. Prentice et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Gene-environment interactions for complex traits: definitions, methodological requirements and challenges
Astrid Dempfle et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms
Xiaoyi Gao et al.
GENETIC EPIDEMIOLOGY (2008)
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer
Simon N. Stacey et al.
NATURE GENETICS (2007)
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
David J. Hunter et al.
NATURE GENETICS (2007)
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton et al.
NATURE (2007)
Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women
SS Tworoger et al.
CANCER RESEARCH (2006)
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes
DJ Hunter et al.
NATURE REVIEWS CANCER (2005)
The Nurses' Health Study: Lifestyle and health among women
GA Colditz et al.
NATURE REVIEWS CANCER (2005)
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
GL Anderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Breast cancer and hormone-replacement therapy: the Million Women Study - Reply
V Beral et al.
LANCET (2003)
European prospective investigation into cancer and nutrition (EPIC):: study populations and data collection
E Riboli et al.
PUBLIC HEALTH NUTRITION (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
The American Cancer Society cancer prevention study II nutrition cohort - Rationale, study design, and baseline characteristics
EE Calle et al.
CANCER (2002)
Intake of fruits and vegetables and risk of breast cancer - A pooled analysis of cohort studies
SA Smith-Warner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
RB Hayes et al.
CONTROLLED CLINICAL TRIALS (2000)
Baseline characteristics of participants in the women's health study
KM Rexrode et al.
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE (2000)
Share Paper
